Correction to: The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro‑entero‑pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu] Lu‑DOTATATE

期刊论文
发表日期：

2025年6月6日

查看全文

Marco Maccauro,
Mariarosaria Cuomo,
Matteo Bauckneht,
Matteo Bagnalasta,
Stefania Mazzaglia,
Federica Scalorbi,
Giovanni Argiroffi,
Margarita Kirienko,
Alice Lorenzoni,
Gianluca Aliberti,
Sara Pusceddu,
Calareso Giuseppina,
Enrico Matteo Garanzini,
Ettore Seregni,
Carlo Chiesa

本文未提供摘要，请点击“查看全文”查看完整内容。